<!DOCTYPE html>
<html>
<head>

<style>
* {
  box-sizing: border-box;
}
body {
  margin: 0;
  font-family: "Lato", sans-serif;
  /*agregar color oscuro para el fondo*/
  background: #f1f1f1;
}
  /* Header/Logo Title */
.bg-image {
  /* The image used */
  background-image:url('bg.jpg');
  
  /* Add the blur effect */
  filter: blur(8px);
  -webkit-filter: blur(8px);
  
  /* Full height */
  height: 100%; 
  
  /* Center and scale the image nicely */
  background-position: center;
  background-repeat: no-repeat;
  background-size: cover;
}

/* Position text in the middle of the page/image */
.bg-text {
  background-color: rgb(0,0,0); /* Fallback color */
  background-color: rgba(0,0,0, 0.4); /* Black w/opacity/see-through */
  color: white;
  font-weight: bold;
  border: 3px solid #f1f1f1;
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  z-index: 2;
  width: 80%;
  padding: 20px;
  text-align: center;
}
.header {
  padding: 1px;
  text-align: center;
  background: linear-gradient(to bottom, 	#254666 30%, #4d667f 100%);
  color: white;
  font-size: 20px;
  margin-left: 200px;
} 
.center {
  display: block;
  margin-left: auto;
  margin-right: auto;
  width: 50%;
}
  .sidebar {
  margin: 0;  
  padding: 0;
  width: 200px;
  background-color: #FFFFFF;
  position: fixed;
  height: 100%;
  overflow: auto;
}
.sidebar a {
  display: block;
  color: black;
  padding: 16px;
  text-decoration: none;
} 
.sidebar a.active {
  background-color: #294e71;
  color: white;
}
.sidebar a:hover:not(.active) {
  background-color: #4d667f;
  color: white;
}

div.content {
  margin-left: 200px;
  padding: 1px 16px;
  height: 1000px;
}

@media screen and (max-width: 100px) {
  .sidebar {
    width: 100%;
    height: auto;
    position: relative;
  }
  .sidebar a {float: left;}
  div.content {margin-left: 0;}
}

@media screen and (max-width: 100px) {
  .sidebar a {
    text-align: center;
    float: none;
  }
}
  .card {
   background-color: white;
   padding: 20px;
   margin-top: 10px;
   margin-left: 230px;
   margin-right:30px;
   margin-bottom: 10px;
   box-shadow: 5px 5px 5px #888888;
}
  .table {
  font-family: arial, sans-serif;
  border-collapse: collapse;
  width: 100%;
}
td, th {
  border: 1px solid #dddddd;
  text-align: left;
  padding: 8px;
}

tr:nth-child(even) {
  background-color: #dddddd;
}
  
.column {
  float: left;
  width: 20%;
  padding: 0 10px;
}
.left {
  width: 60%;
}
.right {
  width: 40%;
}
/* Remove extra left and right margins, due to padding */
.row {margin: -5px -5px;
}
/* Clear floats after the columns */
.row:after {
  content: "";
  display: table;
  clear: both;
}
</style>
</head>
<body>

  
<div class="sidebar">
  <br>
  <img src="/media/Logo.jpg" alt="Logo" style="width:90%;max-width:500px" class="center">
  <a class="active" href="#1_about_us">About us</a>
  <a href="/2_research">Research</a>
  <a href="/3_publications">Publications</a>
  <a href="/4_members">Members</a>
  <a href="/5.1_resourses">Resourses</a>
  <a href="/5_join_us">Join us</a>
  <a href="/6_events">Events & News</a>
  <a href="/7_contact">Contact</a>
</div>
  
<div class="header">
  <h1>Ramírez Lab </h1>
  <p>Computational Biophysics, Bioinformatics & Drug Design</p>
  </div>


<div class="card">
  <h2>Welcome to the Ramírez Lab</h2>
  <div class="bg-image"></div>
  <p align="justify">We are a multidisciplinary group focusing on the study of biomolecular systems 
    by using both, computational and experimental approaches. We aim to use computational methods - broadening 
    the way to describe biology phenomena - to combine and use them together with wet lab analyses for 
    drug design and development processes. Our work involves collaboration with medicinal chemists, 
    biochemists, and biologists, and we are part of the Institute of Biomedical Sciences at Universidad 
    Autónoma de Chile.</p>
</div>
  
<div class="card">
  <h2><a href="/2_research">Active research areas</a></h2>
  <li align="justify">Structural insights into the substrate specificity and transport mechanisms in the Nitrate/Peptide Transporter (NPF) Family</li><br> 
  <li align="justify">Multi-target drug design against neurodegenerative diseases</li><br>
  <li align="justify">Drug design of novel antimicrobial agents</li><br>
  <li align="justify">Understanding the binding mechanisms of endo and phytocannabinoids into the human CB1 receptor</li><br>
</div>

<div class="card">
  <h2><a href="/3_publications">Latest publication</a></h2>
       <h3><a href="https://www.sciencedirect.com/science/article/pii/S1476927119311089" target="_blank">Structural and functional computational analysis of nicotine analogs as T potential neuroprotective compounds in Parkinson disease</a></h3>
       <h5>Gina Paola Becerra, Felipe Rojas-Rodríguez, David Ramírez, Alix E. Loaiza, Fabian Tobar-Tosse, Sol M. Mejía, & Janneth González.</h5>
   <p>Computational Biology and Chemistry, 2020, doi: 10.1016/j.compbiolchem.2020.107266</p>
      <div class="row">
      <div class="column left">
      <p align="justify">As the mechanism of interaction between nicotinic receptors with nicotine analogs is not yet 
        fully understood, information at molecular level obtained from computational calculations is needed. In this 
        sense, this work is a computational study of eight nicotine analogs, all with pyrrolidine ring modifications 
        over a nicotine-based backbone optimized with B3LYP-D3/aug-cc-pVDZ. A molecular characterization was performed 
        focusing on geometrical parameters such as pseudo-rotation angles, atomic charges, HOMO and LUMO orbitals, 
        reactivity indexes and intermolecular interactions. Three analogs, A2 (3-(1,3-dimethyl-4,5-dihydro-1h-pirazole-5-yl) 
        pyr- idine), A3 (3-(3-methyl-4,5-dihydro-1H-pyrazol-5-yl)-pyridine) and A8 (5-methyl-3-(pyridine-3-yl)-4,5-dihy-
        droisoxazole), were filtered suggesting putative neuroprotective activity taking into account different reactivity 
        values, such as their lowest hardness: 2.37 eV (A8), 2.43 eV (A2) and 2.56 eV (A3), compared to the highest hardness 
        value found: 2.71 eV for A5 (3-((2S,4R)-4-(fluoromethyl)-1-methylpyrrolidine-2-il) pyridine), similar to the value 
        of nicotine (2.70 eV). Additionally, molecular docking of all 8 nicotine analogs with the α 7 nicotinic acetylcholine 
        receptor (α 7 nAChR) was performed. High values of interaction between the receptor and the three nicotine analogs 
        were obtained: A3 (-7.1 kcal/mol), A2 (-6.9 kcal/mol) and A8 (-6.8 kcal/mol); whereas the affinity energy of 
        nicotine was -6.4 kcal/mol. Leu116 and Trp145 are key residues in the binding site of α 7 nAChR interacting 
        with nicotine analogs. Therefore, based upon these results, possible application of these nicotine analogs as 
        neuroprotective compounds and potential implication at the design of novel Parkinson's treatments is evidenced.</p>
      </div> 
      <div class ="column right">
      img src="/media/2020-2-ComBiolChem-Abstract.png" style="width:60%"
      </div></div>
</div>  

  
 
<div class="card">
  <h2>Funding</h2>
  <table>
  <tr>
    <th>Grant</th>
    <th>Funded by</th>
    <th>Role</th>
    <th>Date</th>
  </tr>
  <tr>
    <td>Multi-Target Drug Design Against Neurodegenerative Diseases.</td>
    <td>Conicyt No. REDES190074</td>
    <td>Principal Investigator</td>
    <td>2020 - 2021</td>
  </tr>
  <tr>
    <td>INSECTR – International Network to Study Secondary Metabolite Transport In Plants.</td>
    <td>Conicyt No. REDES1900254</td>
    <td>Associate Investigator</td>
    <td>2020 - 2021</td>
  </tr>
  <tr>
    <td>Identificación de reacciones controladoras de lipotoxicidad inducida por ácido palmítico en un modelo computacional multiómico astrocitario.</td>
    <td>Colciencias No. 67270 (Colombia)</td>
    <td>Co-investigator</td>
    <td>2020 - 2022</td>
  </tr>   
  <tr>
    <td>Scholarship Programme for Young Professors and Researchers from Latin American Universities.</td>
    <td>Coimbra group</td>
    <td>Principal Investigator</td>
    <td>2019</td>
  </tr>
  <tr>
    <td>Structural insights into the substrate specificity and transport mechanisms in the Nitrate/Peptide Transporter (NPF) Family.</td>
    <td>Fondecyt No. 11180604</td>
    <td>Principal Investigator</td>
    <td>2018 – 2021</td>
  </tr>
  <tr>
    <td>Análisis metabolómico de los efectos neuroprotectores de la tibolona en un modelo astrocitico humano de lipotoxicidad con ácido palmítico.</td>
    <td>Colciencias</td>
    <td>International Advisor</td>
    <td>2017 - 2020</td>
  </tr>
</table>
</div>  

</body>
</html>
